Pedro Cruz-Nova

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Single Molecule

Positron Emission Tomography

Top Venues

Nanomaterials (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G Aguirre-De Paz, Pedro Cruz-Nova, Gerardo Bravo-Villegas, Joel E Vargas-Ahumada, Paola Vallejo-Armenta, Enrique Morales-Ávila, Nallely Jiménez-Mancilla, Rigoberto Oros-Pantoja, Clara Leticia Santos Cuevas, Erika Azorín-Vega, Blanca Ocampo-Garcia, Guillermina Ferro-Flores
68 Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases. Pharmaceutics 16 (4) (2024)
Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G Aguirre-De Paz, Pedro Cruz-Nova, Gerardo Bravo-Villegas, Joel E Vargas-Ahumada, Paola Vallejo-Armenta, Enrique Morales-Ávila, Nallely Jiménez-Mancilla, Rigoberto Oros-Pantoja, Clara Leticia Santos Cuevas, Erika Azorín-Vega, Blanca Ocampo-Garcia, Guillermina Ferro-Flores
68 Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases. Pharmaceutics 16 (4) (2024)
Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Francisco Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Leticia Santos Cuevas
99m Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe. Pharmaceutics 15 (12) (2023)
Myrna Luna-Gutiérrez, Pedro Cruz-Nova, Nallely Jiménez-Mancilla, Rigoberto Oros-Pantoja, Nancy Lara-Almazán, Clara Leticia Santos Cuevas, Erika Azorín-Vega, Blanca Ocampo-Garcia, Guillermina Ferro-Flores
Synthesis and Evaluation of 177 Lu-DOTA-PD-L1-i and 225 Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy. International journal of molecular sciences 24 (15) (2023)
Blanca Ocampo-Garcia, Pedro Cruz-Nova, Nallely Jiménez-Mancilla, Myrna Luna-Gutiérrez, Rigoberto Oros-Pantoja, Nancy Lara-Almazán, Diana Pérez-Velasco, Clara Leticia Santos Cuevas, Guillermina Ferro-Flores
225 Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins. International journal of molecular sciences 24 (23) (2023)
Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Francisco Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Leticia Santos Cuevas
99m Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe. Pharmaceutics 15 (12) (2023)
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-Garcia, Clara Leticia Santos Cuevas, Enrique Morales-Ávila, Guillermina Ferro-Flores
Toxicity Assessment of [ 177 Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-Garcia, Clara Leticia Santos Cuevas, Enrique Morales-Ávila, Guillermina Ferro-Flores
Toxicity Assessment of [ 177 Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-Garcia, Clara Leticia Santos Cuevas, Enrique Morales-Ávila, Guillermina Ferro-Flores
Toxicity Assessment of [ 177 Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Pedro Cruz-Nova, Alejandra Ancira-Cortez, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Brenda Gibbens-Bandala
Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer. Pharmaceutics 14 (5) (2022)